Tim Hohm

Tim Hohm is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as Associate Director at Novo Nordisk, where efforts focus on transforming Research & Early Development through digital-AI initiatives and external partnerships. Prior experience includes leading Business Development and Competitive Intelligence at e-therapeutics PLC, enhancing partnerships around gene-silencing therapeutics, and directing Commercial Strategy at Optibrium Ltd., contributing to preclinical drug discovery solutions. Earlier roles at Novo Nordisk involved senior management in competitor intelligence and strategic sourcing within delivery technology R&D. Tim’s academic background includes a Master of Business Administration from Copenhagen Business School, a Dr. sc. in Computational Biology from ETH Zürich, and a Diplom in Computer Science from TU Dortmund University.